| scholarly article | Q13442814 |
| P50 | author | Brice Sperandio | Q58314751 |
| P2093 | author name string | Philippe J Sansonetti | |
| Zhi Zhang | |||
| Béatrice Regnault | |||
| Jianhua Guo | |||
| Samuel L Stanley | |||
| Thierry Pédron | |||
| P2860 | cites work | Beta-defensins: linking innate and adaptive immunity through dendritic and T cell CCR6 | Q22010648 |
| Cell differentiation is a key determinant of cathelicidin LL-37/human cationic antimicrobial protein 18 expression by human colon epithelium | Q24537181 | ||
| Interaction of human defensins with Escherichia coli. Mechanism of bactericidal activity | Q24556650 | ||
| Shigella flexneri enters human colonic Caco-2 epithelial cells through the basolateral pole | Q24646749 | ||
| Innate immune recognition | Q27860721 | ||
| Exploration, normalization, and summaries of high density oligonucleotide array probe level data | Q27861098 | ||
| Antimicrobial peptides of multicellular organisms | Q28131811 | ||
| Phylogenetic perspectives in innate immunity | Q28144345 | ||
| Defensins: antimicrobial peptides of innate immunity | Q28204453 | ||
| Correlation between beta-defensin expression and induction profiles in gingival keratinocytes | Q28245011 | ||
| Host-pathogen interactions: subversion and utilization of the NF-kappa B pathway during infection | Q28386446 | ||
| Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? | Q29547675 | ||
| Interactions between commensal intestinal bacteria and the immune system | Q29617039 | ||
| Many chemokines including CCL20/MIP-3alpha display antimicrobial activity. | Q29871487 | ||
| Local-pooled-error test for identifying differentially expressed genes with a small number of replicated microarrays | Q30311902 | ||
| Emerging patterns and gene expression data. | Q30670078 | ||
| Yeast functional genomic screens lead to identification of a role for a bacterial effector in innate immunity regulation | Q33274199 | ||
| Molecular bases of epithelial cell invasion by Shigella flexneri | Q33542385 | ||
| Regulation of dendritic cell trafficking: a process that involves the participation of selective chemokines | Q33712280 | ||
| The Shigella flexneri effector OspG interferes with innate immune responses by targeting ubiquitin-conjugating enzymes | Q34048081 | ||
| Intestinal IgA synthesis: regulation of front-line body defences | Q34168492 | ||
| Improved outcome in shigellosis associated with butyrate induction of an endogenous peptide antibiotic | Q34694936 | ||
| Enteric salmonella infection inhibits Paneth cell antimicrobial peptide expression | Q34716119 | ||
| Rapid assessment of antibiotic effects on Escherichia coli by bis-(1,3-dibutylbarbituric acid) trimethine oxonol and flow cytometry. | Q35138198 | ||
| Signal transduction and nuclear responses in Staphylococcus aureus-induced expression of human beta-defensin 3 in skin keratinocytes | Q35220350 | ||
| Human intestinal epithelial cells produce proinflammatory cytokines in response to infection in a SCID mouse-human intestinal xenograft model of amebiasis. | Q35546207 | ||
| The immune response of Drosophila | Q35577920 | ||
| Mammalian defensins in the antimicrobial immune response | Q36134856 | ||
| Acute inflammation causes epithelial invasion and mucosal destruction in experimental shigellosis | Q36363758 | ||
| Involvement of a plasmid in the invasive ability of Shigella flexneri. | Q36437346 | ||
| The co-evolution of host cationic antimicrobial peptides and microbial resistance | Q36508686 | ||
| Nod-like proteins in immunity, inflammation and disease | Q36655897 | ||
| Debugging how bacteria manipulate the immune response. | Q36739044 | ||
| Paneth cells, defensins, and the commensal microbiota: a hypothesis on intimate interplay at the intestinal mucosa | Q36813569 | ||
| Structure and function of the intestinal epithelial barrier in health and disease | Q38142953 | ||
| NF-kappaB- and AP-1-mediated induction of human beta defensin-2 in intestinal epithelial cells by Escherichia coli Nissle 1917: a novel effect of a probiotic bacterium. | Q40017434 | ||
| The phosphothreonine lyase activity of a bacterial type III effector family | Q40170436 | ||
| An injected bacterial effector targets chromatin access for transcription factor NF-kappaB to alter transcription of host genes involved in immune responses | Q40198172 | ||
| Neisseria gonorrhoeae downregulates expression of the human antimicrobial peptide LL-37. | Q40410408 | ||
| Role of M cells in initial antigen uptake and in ulcer formation in the rabbit intestinal loop model of shigellosis | Q40426449 | ||
| Cathelicidins: a novel protein family with a common proregion and a variable C‐terminal antimicrobial domain | Q40432691 | ||
| Up-regulation of human beta-defensin 2 by interleukin-1beta in A549 cells: involvement of PI3K, PKC, p38 MAPK, JNK, and NF-kappaB. | Q40538294 | ||
| Differential expression of sucrase-isomaltase in clones isolated from early and late passages of the cell line Caco-2: evidence for glucose-dependent negative regulation | Q41498843 | ||
| MxiD, an outer membrane protein necessary for the secretion of the Shigella flexneri lpa invasins | Q41504166 | ||
| Shigella flexneri induces apoptosis in infected macrophages | Q41614246 | ||
| Differential regulation of beta-defensin expression in human skin by microbial stimuli | Q44742019 | ||
| SepA, the 110 kDa protein secreted by Shigella flexneri: two-domain structure and proteolytic activity | Q47721067 | ||
| Multiple roles of antimicrobial defensins, cathelicidins, and eosinophil-derived neurotoxin in host defense | Q47922120 | ||
| Type III secretion effectors of the IpaH family are E3 ubiquitin ligases | Q50066742 | ||
| The invasive phenotype of Shigella flexneri directs a distinct gene expression pattern in the human intestinal epithelial cell line Caco-2. | Q52952279 | ||
| Regulation of transcription by the activity of the Shigella flexneri type III secretion apparatus. | Q54546861 | ||
| Downregulation of bactericidal peptides in enteric infections: a novel immune escape mechanism with bacterial DNA as a potential regulator | Q57940216 | ||
| The host-pathogen interaction: new themes from dendritic cell biology | Q74386851 | ||
| Analysis of virulence plasmid gene expression defines three classes of effectors in the type III secretion system of Shigella flexneri | Q81503204 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | antimicrobial peptide | Q1201508 |
| Shigella flexneri | Q1644417 | ||
| P304 | page(s) | 1121-1132 | |
| P577 | publication date | 2008-04-21 | |
| P1433 | published in | Journal of Experimental Medicine | Q3186912 |
| P1476 | title | Virulent Shigella flexneri subverts the host innate immune response through manipulation of antimicrobial peptide gene expression | |
| P478 | volume | 205 |
| Q34229724 | A shared role for RBF1 and dCAP-D3 in the regulation of transcription with consequences for innate immunity |
| Q45950129 | Analysis of Shigella flexneri-mediated infections in model organism Caenorhabditis elegans. |
| Q26991811 | Antibiotic development challenges: the various mechanisms of action of antimicrobial peptides and of bacterial resistance |
| Q34533569 | Antimicrobial Human β-Defensins in the Colon and Their Role in Infectious and Non-Infectious Diseases |
| Q33742102 | Antimicrobial Peptides: Primeval Molecules or Future Drugs? |
| Q37539812 | Autophagy at the gut interface: mucosal responses to stress and the consequences for inflammatory bowel diseases |
| Q30579709 | B lymphocytes undergo TLR2-dependent apoptosis upon Shigella infection |
| Q36720179 | Bacterial Evasion of Host Antimicrobial Peptide Defenses |
| Q38891403 | CCL20 Displays Antimicrobial Activity Against Cryptosporidium parvum, but Its Expression Is Reduced During Infection in the Intestine of Neonatal Mice. |
| Q43599511 | CCL20 is overexpressed in Mycobacterium tuberculosis-infected monocytes and inhibits the production of reactive oxygen species (ROS). |
| Q41869149 | Characterization of Antimicrobial Peptides toward the Development of Novel Antibiotics |
| Q64058328 | Differential Expression of Antimicrobial Peptides in Streptococcus pneumoniae Keratitis and STAT3-Dependent Expression of LL-37 by Streptococcus pneumoniae in Human Corneal Epithelial Cells |
| Q34265202 | Efficacy of sodium butyrate adjunct therapy in shigellosis: a randomized, double-blind, placebo-controlled clinical trial |
| Q34454677 | Endogenous cathelicidin production limits inflammation and protective immunity to Mycobacterium avium in mice. |
| Q60584774 | Enterobacteria and host resistance to infection |
| Q35035519 | Expression and antimicrobial function of beta-defensin 1 in the lower urinary tract |
| Q40603856 | Flagellin Induces β-Defensin 2 in Human Colonic Ex vivo Infection with Enterohemorrhagic Escherichia coli. |
| Q35079356 | Genome-wide immunity studies in the rabbit: transcriptome variations in peripheral blood mononuclear cells after in vitro stimulation by LPS or PMA-Ionomycin |
| Q34495298 | Host defense peptides: an alternative as antiinfective and immunomodulatory therapeutics |
| Q39230762 | How Do the Virulence Factors of Shigella Work Together to Cause Disease? |
| Q54204997 | Human Metapneumovirus Infection Inhibits Cathelicidin Antimicrobial Peptide Expression in Human Macrophages. |
| Q37689038 | Human beta-defensin 3 contributes to the carcinogenesis of cervical cancer via activation of NF-κB signaling |
| Q37609824 | Human defensins and LL-37 in mucosal immunity. |
| Q38636542 | Injection of T3SS effectors not resulting in invasion is the main targeting mechanism of Shigella toward human lymphocytes |
| Q33887808 | Innate immune responses of a scleractinian coral to vibriosis |
| Q33508806 | Innate immune responses of pulmonary epithelial cells to Burkholderia pseudomallei infection |
| Q38054086 | Intestinal antimicrobial peptides during homeostasis, infection, and disease |
| Q35541353 | Mechanisms of Antimicrobial Peptide Resistance in Gram-Negative Bacteria |
| Q34931987 | Modulation of early β-defensin-2 production as a mechanism developed by type I Toxoplasma gondii to evade human intestinal immunity |
| Q28478430 | Phenylbutyrate counteracts Shigella mediated downregulation of cathelicidin in rabbit lung and intestinal epithelia: a potential therapeutic strategy |
| Q36389493 | Polydim-I antimicrobial activity against MDR bacteria and its model membrane interaction |
| Q36379497 | Preventing acute gut wall damage in infectious diarrhoeas with glycosylated dendrimers |
| Q34295528 | Quantitative RT-PCR profiling of the rabbit immune response: assessment of acute Shigella flexneri infection |
| Q34375210 | Recent advances in understanding enteric pathogenic Escherichia coli. |
| Q37984651 | Resistance to antimicrobial peptides in Gram-negative bacteria. |
| Q26752367 | Shigella Diversity and Changing Landscape: Insights for the Twenty-First Century |
| Q37229647 | Shigella flexneri suppresses NF-κB activation by inhibiting linear ubiquitin chain ligation |
| Q24315859 | Shigella flexneri type III secretion system effectors OspB and OspF target the nucleus to downregulate the host inflammatory response via interactions with retinoblastoma protein |
| Q30537978 | Shigella impairs T lymphocyte dynamics in vivo |
| Q92968788 | Shigella-mediated immunosuppression in the human gut: subversion extends from innate to adaptive immune responses |
| Q27687005 | Shigella: a model of virulence regulation in vivo |
| Q37410374 | Susceptibility to infectious diseases based on antimicrobial peptide production |
| Q35073029 | Synthesis, 68Ga-radiolabeling, and preliminary in vivo assessment of a depsipeptide-derived compound as a potential PET/CT infection imaging agent |
| Q38909275 | The Orchestra and Its Maestro: Shigella's Fine-Tuning of the Inflammasome Platforms. |
| Q34402880 | The Shigella dysenteriae serotype 1 proteome, profiled in the host intestinal environment, reveals major metabolic modifications and increased expression of invasive proteins |
| Q58107290 | The infection of Harmonia axyridis by a parasitic nematode is mediated by entomopathogenic bacteria and triggers sex-specific host immune responses |
| Q41852006 | The serine protease plasmin triggers expression of the CC-chemokine ligand 20 in dendritic cells via Akt/NF-κB-dependent pathways. |
| Q40239307 | Treatment with Entinostat Heals Experimental Cholera by Affecting Physical and Chemical Barrier Functions of Intestinal Epithelia |
| Q33613845 | Treponema denticola suppresses expression of human {beta}-defensin-3 in gingival epithelial cells through inhibition of the toll-like receptor 2 axis |
| Q37461382 | Update on Campylobacter jejuni vaccine development for preventing human campylobacteriosis. |
| Q42038460 | Virulent Shigella flexneri affects secretion, expression, and glycosylation of gel-forming mucins in mucus-producing cells |
Search more.